Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Preferred Shares (2020)

Historic Preferred Shares for Gain Therapeutics (GANX) over the last 1 years, with Q4 2020 value amounting to $297.0.

  • Gain Therapeutics' Preferred Shares changed N/A to $297.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $297.0, marking a year-over-year change of. This contributed to the annual value of $297.0 for FY2020, which is N/A changed from last year.
  • Gain Therapeutics' Preferred Shares amounted to $297.0 in Q4 2020.
  • Gain Therapeutics' 5-year Preferred Shares high stood at $297.0 for Q4 2020, and its period low was $297.0 during Q4 2020.